RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 Comparison of Tedizolid Phosphate versus Linezolid in a Phase 3 Study in Patients with ABSSSI
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 14
SP 28
OP 29
DO 10.1177/155989771214014
UL http://mdc.sagepub.com/content/12/14/28.2.abstract
AB In a Phase 3 study comparing tedizolid, a second generation oxazolidinone, to linezolid in patients with acute bacterial skin and skin structure infections (ABSSSI), tedizolid phosphate was noninferior and demonstrated high microbiological efficacy compared with linezolid. This article presents a poster [De Anda et al. ICAAC 2012 L1–1665] on the outcomes using the the new Food and Drug Administration method for assessing clinical response, programmatic assessment, and the traditional post-treatment investigator assessment.